These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 18614497)
21. Sponsorship of educational programmes in Nigerian medical and pharmacy schools by pharmaceutical companies: possible risk implication for public health. Okoro EO; Davies AE Ethics Med; 2001; 17(1):52-60. PubMed ID: 15176368 [No Abstract] [Full Text] [Related]
22. Pharma PR or medical education? Roselin JM Hastings Cent Rep; 2005; 35(2):5-6. PubMed ID: 15957305 [No Abstract] [Full Text] [Related]
23. For-profit health plans. Buxton AE; Josephson ME N Engl J Med; 1996 Aug; 335(6):436; author reply 437-8. PubMed ID: 8676943 [No Abstract] [Full Text] [Related]
24. Federal research funding at U.S. universities and colleges and the production of underrepresented-minority physicians. Cummings SM Acad Med; 1998 Oct; 73(10):1122. PubMed ID: 9795634 [No Abstract] [Full Text] [Related]
25. Pharma PR or medical education? Sweeney HA Hastings Cent Rep; 2005; 35(2):4; author reply 5. PubMed ID: 15957304 [No Abstract] [Full Text] [Related]
26. German government considers ending funding of marketing courses for doctors. Tuffs A BMJ; 2012 Aug; 345():e5331. PubMed ID: 22872715 [No Abstract] [Full Text] [Related]
28. Ethical relationships between drug companies and the medical profession. Rosner F Chest; 1992 Jul; 102(1):266-9. PubMed ID: 1623765 [No Abstract] [Full Text] [Related]
29. The addiction of drug companies. Wortis J; Stone A Biol Psychiatry; 1992 Nov; 32(10):847-9. PubMed ID: 1467374 [No Abstract] [Full Text] [Related]
30. Funding of Parkinson research from industry and US federal and foundation sources. Dorsey ER; Thompson JP; Frasier M; Sherer T; Fiske B; Nicholson S; Johnston SC; Holloway RG; Moses H Mov Disord; 2009 Apr; 24(5):731-7. PubMed ID: 19133662 [TBL] [Abstract][Full Text] [Related]
31. Industry Support of Medical Research: Important Opportunity or Treacherous Pitfall? Tierney WM; Meslin EM; Kroenke K J Gen Intern Med; 2016 Feb; 31(2):228-233. PubMed ID: 26307387 [TBL] [Abstract][Full Text] [Related]
32. Funding for medicine at UMC would benefit all Missourians. Crist WM; Hugh E; Stephenson SD Mo Med; 2006; 103(2):138. PubMed ID: 16703711 [No Abstract] [Full Text] [Related]
33. Industry-supported meta-analyses compared with meta-analyses with non-profit or no support: differences in methodological quality and conclusions. Jørgensen AW; Maric KL; Tendal B; Faurschou A; Gøtzsche PC BMC Med Res Methodol; 2008 Sep; 8():60. PubMed ID: 18782430 [TBL] [Abstract][Full Text] [Related]
34. Industry support of medical education. Relman AS JAMA; 2008 Sep; 300(9):1071-3. PubMed ID: 18768419 [No Abstract] [Full Text] [Related]
36. Canadian drug companies fund universities. Spurgeon D Nature; 1993 Jun; 363(6429):484. PubMed ID: 8505969 [No Abstract] [Full Text] [Related]
37. [Let the profit from drug advertisement in Lakartidningen go to a research foundation!]. Järhult B Lakartidningen; 2006 Jan 25-31; 103(4):226; discussion 227, 231-3. PubMed ID: 16491557 [No Abstract] [Full Text] [Related]
38. Not-for-profit drugs--no longer an oxymoron? Sharp D Lancet; 2004 Oct 23-29; 364(9444):1472-4. PubMed ID: 15500876 [No Abstract] [Full Text] [Related]
39. The government, medical education and research. Bain J J R Coll Gen Pract; 1988 Jul; 38(312):293-4. PubMed ID: 3255822 [No Abstract] [Full Text] [Related]